Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

Clinical trial NCT03584165 · COMPLETED

Trial details

NCT number: NCT03584165
Sponsor: NightstaRx Ltd, a Biogen Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Choroideremia X-Linked Retinitis Pigmentosa

Start date: 2018-06-04
Primary completion: 2026-06-22
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.